BRUKINZA ZANUBRUTINIB Trademark

Trademark Overview

On Wednesday, March 27, 2019, a trademark application was filed for BRUKINZA ZANUBRUTINIB with the United States Patent and Trademark Office. The USPTO has given the BRUKINZA ZANUBRUTINIB trademark a serial number of 88358666. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by BeiGene, Ltd.. The BRUKINZA ZANUBRUTINIB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
brukinza zanubrutinib

General Information

Serial Number88358666
Word MarkBRUKINZA ZANUBRUTINIB
Filing DateWednesday, March 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 7, 2020

Trademark Statements

Description of MarkThe mark consists of an image of a mountain on the left with the words "Brukinza" to the right and the word "zanubrutinib" below it.
Goods and ServicesPharmaceuticals comprising zanubrutinib for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ZANUBRUTINIB"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBeiGene, Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGrand Cayman KY1-1108
KY
Party NameBeiGene, Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1108
KY

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 3, 2022SOU EXTENSION 4 GRANTED
Thursday, February 3, 2022SOU EXTENSION 4 FILED
Thursday, February 3, 2022TEAS EXTENSION RECEIVED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 1, 2021SOU EXTENSION 3 GRANTED
Wednesday, September 1, 2021SOU EXTENSION 3 FILED
Wednesday, September 1, 2021TEAS EXTENSION RECEIVED
Friday, February 5, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, January 28, 2021SOU EXTENSION 2 GRANTED
Thursday, January 28, 2021SOU EXTENSION 2 FILED
Thursday, January 28, 2021TEAS EXTENSION RECEIVED
Thursday, August 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 18, 2020SOU EXTENSION 1 GRANTED
Tuesday, August 18, 2020SOU EXTENSION 1 FILED
Tuesday, August 18, 2020TEAS EXTENSION RECEIVED
Monday, May 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 18, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, December 5, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 5, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, December 5, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, December 5, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, December 5, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 5, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, December 5, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 4, 2019PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 18, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, May 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2019ASSIGNED TO EXAMINER
Tuesday, April 16, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, April 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 30, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

zanubrutinib brukinza diseases inflammatory infectious autoimmune cancer comprising treatment pharmaceuticals